News

I’m very lucky to have access to some of the world’s top dermatologists and skincare professionals thanks to my line of work.
Paige DeSorbo called Aquaphor’s Healing Balm Stick “the go-to” in an Amazon livestream on Wednesday, and shared one of her ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Roche has parted with $1.4 billion upfront to secure rights to an obesity candidate developed by Zealand Pharma, taking its tally of weight-loss candidates in clinical development to five.
An experimental therapy for Parkinson's disease being developed by Roche and Prothena has missed the mark in a phase 2b trial, leaving them sifting through the data for signals of efficacy.
Click the FOLLOW button to be the first to know about this artist's upcoming lots, sold lots, exhibitions and articles Carole Laroche is a Postwar & Contemporary artist. How much does a Carole Laroche ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Roche is stop­ping pa­tients on the low dose of its ex­per­i­men­tal Hunt­ing­ton’s drug tomin­ersen, and will be tran­si­tion­ing them to the high dose fol­low­ing rec­om­men ...
This week, we heard an update from Roche about their huntingtin-lowering therapy, tominersen, currently being tested in the GENERATION HD2 trial. An independent data monitoring committee (iDMC) that ...